214 related articles for article (PubMed ID: 26792343)
1. Higher expression of TNFα-induced genes in the synovium of patients with early rheumatoid arthritis correlates with disease activity, and predicts absence of response to first line therapy.
De Groof A; Ducreux J; Humby F; Nzeusseu Toukap A; Badot V; Pitzalis C; Houssiau FA; Durez P; Lauwerys BR
Arthritis Res Ther; 2016 Jan; 18():19. PubMed ID: 26792343
[TBL] [Abstract][Full Text] [Related]
2. Global molecular effects of tocilizumab therapy in rheumatoid arthritis synovium.
Ducreux J; Durez P; Galant C; Nzeusseu Toukap A; Van den Eynde B; Houssiau FA; Lauwerys BR
Arthritis Rheumatol; 2014 Jan; 66(1):15-23. PubMed ID: 24449571
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling in the synovium identifies a predictive signature of absence of response to adalimumab therapy in rheumatoid arthritis.
Badot V; Galant C; Nzeusseu Toukap A; Theate I; Maudoux AL; Van den Eynde BJ; Durez P; Houssiau FA; Lauwerys BR
Arthritis Res Ther; 2009; 11(2):R57. PubMed ID: 19389237
[TBL] [Abstract][Full Text] [Related]
4. Responsiveness to anti-tumour necrosis factor alpha therapy is related to pre-treatment tissue inflammation levels in rheumatoid arthritis patients.
van der Pouw Kraan TC; Wijbrandts CA; van Baarsen LG; Rustenburg F; Baggen JM; Verweij CL; Tak PP
Ann Rheum Dis; 2008 Apr; 67(4):563-6. PubMed ID: 18042642
[TBL] [Abstract][Full Text] [Related]
5. The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor alpha expression in the synovium.
Wijbrandts CA; Dijkgraaf MG; Kraan MC; Vinkenoog M; Smeets TJ; Dinant H; Vos K; Lems WF; Wolbink GJ; Sijpkens D; Dijkmans BA; Tak PP
Ann Rheum Dis; 2008 Aug; 67(8):1139-44. PubMed ID: 18055470
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of synovial lymphoid neogenesis and its reversal after anti-tumour necrosis factor alpha therapy in rheumatoid arthritis.
Cañete JD; Celis R; Moll C; Izquierdo E; Marsal S; Sanmartí R; Palacín A; Lora D; de la Cruz J; Pablos JL
Ann Rheum Dis; 2009 May; 68(5):751-6. PubMed ID: 18495732
[TBL] [Abstract][Full Text] [Related]
7. Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics.
Dennis G; Holweg CT; Kummerfeld SK; Choy DF; Setiadi AF; Hackney JA; Haverty PM; Gilbert H; Lin WY; Diehl L; Fischer S; Song A; Musselman D; Klearman M; Gabay C; Kavanaugh A; Endres J; Fox DA; Martin F; Townsend MJ
Arthritis Res Ther; 2014; 16(2):R90. PubMed ID: 25167216
[TBL] [Abstract][Full Text] [Related]
8. A Combined Transcriptomic and Genomic Analysis Identifies a Gene Signature Associated With the Response to Anti-TNF Therapy in Rheumatoid Arthritis.
Aterido A; Cañete JD; Tornero J; Blanco F; Fernández-Gutierrez B; Pérez C; Alperi-López M; Olivè A; Corominas H; Martínez-Taboada V; González I; Fernández-Nebro A; Erra A; López-Lasanta M; López Corbeto M; Palau N; Marsal S; Julià A
Front Immunol; 2019; 10():1459. PubMed ID: 31312201
[No Abstract] [Full Text] [Related]
9. Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients.
Humby F; Lewis M; Ramamoorthi N; Hackney JA; Barnes MR; Bombardieri M; Setiadi AF; Kelly S; Bene F; DiCicco M; Riahi S; Rocher V; Ng N; Lazarou I; Hands R; van der Heijde D; Landewé RBM; van der Helm-van Mil A; Cauli A; McInnes I; Buckley CD; Choy EH; Taylor PC; Townsend MJ; Pitzalis C
Ann Rheum Dis; 2019 Jun; 78(6):761-772. PubMed ID: 30878974
[TBL] [Abstract][Full Text] [Related]
10. Modulatory effects of inflammation and therapy on GDF-5 expression in rheumatoid arthritis synovium.
Bramlage CP; Kaps C; Ungethüm U; Bramlage P; Koziolek M; Wessels J; Krenn V; Pruss A; Müller GA; Strutz F; Burmester GR; Häupl T
Scand J Rheumatol; 2008; 37(6):401-9. PubMed ID: 18830904
[TBL] [Abstract][Full Text] [Related]
11. The relationship between synovial lymphocyte aggregates and the clinical response to infliximab in rheumatoid arthritis: a prospective study.
Klaasen R; Thurlings RM; Wijbrandts CA; van Kuijk AW; Baeten D; Gerlag DM; Tak PP
Arthritis Rheum; 2009 Nov; 60(11):3217-24. PubMed ID: 19877042
[TBL] [Abstract][Full Text] [Related]
12. A Pauci-Immune Synovial Pathotype Predicts Inadequate Response to TNFα-Blockade in Rheumatoid Arthritis Patients.
Nerviani A; Di Cicco M; Mahto A; Lliso-Ribera G; Rivellese F; Thorborn G; Hands R; Bellan M; Mauro D; Boutet MA; Giorli G; Lewis M; Kelly S; Bombardieri M; Humby F; Pitzalis C
Front Immunol; 2020; 11():845. PubMed ID: 32431716
[No Abstract] [Full Text] [Related]
13. Tumour necrosis factor alpha-driven IL-32 expression in rheumatoid arthritis synovial tissue amplifies an inflammatory cascade.
Heinhuis B; Koenders MI; van Riel PL; van de Loo FA; Dinarello CA; Netea MG; van den Berg WB; Joosten LA
Ann Rheum Dis; 2011 Apr; 70(4):660-7. PubMed ID: 21187297
[TBL] [Abstract][Full Text] [Related]
14. Acute-phase serum amyloid A regulates tumor necrosis factor α and matrix turnover and predicts disease progression in patients with inflammatory arthritis before and after biologic therapy.
Connolly M; Mullan RH; McCormick J; Matthews C; Sullivan O; Kennedy A; FitzGerald O; Poole AR; Bresnihan B; Veale DJ; Fearon U
Arthritis Rheum; 2012 Apr; 64(4):1035-45. PubMed ID: 22076945
[TBL] [Abstract][Full Text] [Related]
15. Triple DMARD treatment in early rheumatoid arthritis modulates synovial T cell activation and plasmablast/plasma cell differentiation pathways.
Walsh AM; Wechalekar MD; Guo Y; Yin X; Weedon H; Proudman SM; Smith MD; Nagpal S
PLoS One; 2017; 12(9):e0183928. PubMed ID: 28863153
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of MAP kinase in synovium by treatment with tocilizumab in rheumatoid arthritis.
Kanbe K; Chen Q; Nakamura A; Hobo K
Clin Rheumatol; 2011 Nov; 30(11):1407-13. PubMed ID: 21909699
[TBL] [Abstract][Full Text] [Related]
17. Scoring evaluation for histopathological features of synovium in patients with rheumatoid arthritis during anti-tumor necrosis factor therapy.
Yamanaka H; Goto K; Miyamoto K
Rheumatol Int; 2010 Jan; 30(3):409-13. PubMed ID: 19826823
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of synoviolin in peripheral blood and synoviocytes from rheumatoid arthritis patients and continued elevation in nonresponders to infliximab treatment.
Toh ML; Marotte H; Blond JL; Jhumka U; Eljaafari A; Mougin B; Miossec P
Arthritis Rheum; 2006 Jul; 54(7):2109-18. PubMed ID: 16802346
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment synovial transcriptional profile is associated with early and late clinical response in rheumatoid arthritis patients treated with rituximab.
Hogan VE; Holweg CT; Choy DF; Kummerfeld SK; Hackney JA; Teng YK; Townsend MJ; van Laar JM
Ann Rheum Dis; 2012 Nov; 71(11):1888-94. PubMed ID: 22736099
[TBL] [Abstract][Full Text] [Related]
20. Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: a clue to interpret different chances of relapse after clinical remission?
Alivernini S; Tolusso B; Petricca L; Bui L; Di Sante G; Peluso G; Benvenuto R; Fedele AL; Federico F; Ferraccioli G; Gremese E
Ann Rheum Dis; 2017 Jul; 76(7):1228-1236. PubMed ID: 28119289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
